Pictet Asset Management Holding SA »

Arcutis Biotherapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $173k 19k 9.30

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Suvretta Capital Management
Rubric Capital Management
BlackRock
Frazier Life Sciences Management
Polar Capital Holdings
Vanguard Group
State Street Corporation
Morgan Stanley
Gilder, Gagnon, Howe & Co
Franklin Resources
UBS Group
D. E. Shaw & Co
Geode Capital Management
Ensign Peak Advisors

View all funds holding Arcutis Biotherapeutics